R&D Pipeline
R&D Pipeline
Stock Code: 002653.SZ
Stock code: 002653.SZ
Innovation-driven Pipeline
The Company has more than 20 Class 1 innovative drug projects in clinical development across anesthesia and analgesia, respiratory diseases, chronic metabolic diseases, autoimmune diseases, oncology, and digestive and hepatic diseases. Five Class 1 innovative drugs are moving rapidly toward commercialization.
Anesthesia/Analgesia
Autoimmune Diseases
Chronic Diseases
Autoimmune Disease
Oncology
Others
Sishuning?
Sishuning? (HSK3486 Injection)
Target: Gamma-aminobutyric acid A receptor (GABAa)
Sedation and anesthesia for non-intubatedsurgeries/procedures
IND
Phase 1
Phase 2
Phase 3
NDA
Launched
Sishuning? (HSK3486 Injection)
Target: Gamma-aminobutyric acid A receptor (GABAa)
Induction and maintenance of general anesthesia
IND
Phase 1
Phase 2
Phase 3
NDA
Launched
Sishuning? (HSK3486 Injection)
Target: Gamma-aminobutyric acid A receptor (GABAa)
Sedation during mechanical ventilationin intensive care
IND
Phase 1
Phase 2
Phase 3
NDA
Launched
Sishuning? (HSK3486 Injection)
Target: Gamma-aminobutyric acid A receptor (GABAa)
Pediatric indications (China)
IND
Phase 1
Phase 2
Phase 3
NDA
Launched
Sishuning? (HSK3486 Injection)
Target: Gamma-aminobutyric acid A receptor (GABAa)
Adult General Anesthesia Induction (U.S.)
IND
Phase 1
Phase 2
Phase 3
NDA
Launched
Simeining?
Simeining? (HSK16149 Capsules)
Target: Voltage-gated calcium channels (VGCC)
Diabetic Peripheral Neuropathic Pain (DPNP)
IND
Phase 1
Phase 2
Phase 3
NDA
Launched
Simeining? (HSK16149 Capsules)
Target: Voltage-gated calcium channels (VGCC)
Post Herpetic Neuralgia (PHN)
IND
Phase 1
Phase 2
Phase 3
NDA
Launched
Simeining? (HSK16149 Capsules)
Target: Voltage-gated calcium channels (VGCC)
Central Nervous System Analgesia
IND
Phase 1
Phase 2
Phase 3
NDA
Launched
Sishujing?
Sishujing? (HSK21542 Injection)
Target: Peripheral kappa-opioid receptor (KOR)
Abdominal surgery postoperative pain
IND
Phase 1
Phase 2
Phase 3
NDA
Launched
Sishujing? (HSK21542 Injection)
Target: Peripheral kappa-opioid receptor (KOR)
Orthopedic Analgesia
IND
Phase 1
Phase 2
Phase 3
NDA
Launched
HSK36357
HSK36357
Target: AAK1
Neuropathic Pain
IND
Phase 1
Phase 2
Phase 3
NDA
Launched
HSK55718
HSK55718
Target: Nav1.8
Acute Pain
IND
Phase 1
Phase 2
Phase 3
NDA
Launched
HSK51155
HSK51155
Target: Nav1.8
Migraine / Acute Pain / Chronic Pain
IND
Phase 1
Phase 2
Phase 3
NDA
Launched
Haisco Group's Official WeChat Account
Haisco Investor Relations WeChat Account
Haisco Raw Materials Procurement Inquiries